Shaoji Cheng Selected Research

Infections

1/2017	Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance.
1/2017	Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
7/2015	Coordination of Candida albicans Invasion and Infection Functions by Phosphoglycerol Phosphatase Rhr2.
1/2009	Antibody-based strategy to identify Candida albicans genes expressed during infections.
11/2005	The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaoji Cheng Research Topics

Disease

10	Candidiasis (Moniliasis) 11/2013 - 10/2003
5	Infections 01/2017 - 11/2005
3	Invasive Candidiasis 09/2012 - 05/2006
1	Mucormycosis 01/2022
1	Exanthema (Rash) 01/2017
1	Pseudomonas Infections 01/2017
1	Cholangitis 09/2016
1	Abscess 11/2013
1	Blister (Bulla) 01/2013
1	Necrosis 01/2013
1	Aspergillosis 12/2012
1	Candidemia 09/2012
1	Abdominal Abscess 09/2012
1	Systemic candidiasis 05/2008
1	Growth Disorders 02/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2006
1	Meningoencephalitis 08/2006
1	Vulvovaginal Candidiasis 11/2005
1	Oral Candidiasis (Thrush) 06/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 05/2013 - 11/2005
3	Immunoglobulin G (IgG)IBA 12/2012 - 05/2006
2	Caspofungin (Cancidas)FDA Link 01/2013 - 09/2012
2	AntibodiesIBA 04/2009 - 11/2008
2	Immunoglobulin M (IgM)IBA 05/2008 - 05/2006
2	AntigensIBA 05/2008 - 06/2003
2	Virulence Factors (Pathogenicity Factors)IBA 08/2006 - 09/2005
1	ceftazidime drug combination avibactamIBA 01/2017
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2017
1	tazobactam drug combination ceftolozaneIBA 01/2017
1	Fluconazole (Zonal)FDA LinkGeneric 09/2016
1	RNA (Ribonucleic Acid)IBA 09/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2015
1	Biological ProductsIBA 11/2013
1	Peptide Hydrolases (Proteases)FDA Link 11/2013
1	Propidium (Propidium Iodide)IBA 01/2013
1	ChromatinIBA 01/2013
1	Annexin A5IBA 01/2013
1	PhosphatidylserinesIBA 01/2013
1	EchinocandinsIBA 09/2012
1	polyglucosanIBA 05/2012
1	Anidulafungin FDA Link 08/2009
1	Cortisone FDA Link 01/2009
1	Epidermal Growth Factor (EGF)IBA 11/2008
1	EnzymesIBA 05/2008
1	ImmunosorbentsIBA 05/2008
1	Glucose (Dextrose)FDA LinkGeneric 02/2007
1	CarbohydratesIBA 02/2007
1	Immunoglobulins (Immunoglobulin)IBA 05/2006
1	MethyltransferasesIBA 05/2006
1	Histones (Histone)IBA 05/2006
1	Lysine (L-Lysine)FDA Link 05/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2005
1	orotidylic acidIBA 10/2003
1	Carboxy-LyasesIBA 10/2003

Therapy/Procedure

1	Bedding and Linens (Linens) 01/2022
1	Aftercare (After-Treatment) 09/2016
1	Drug Therapy (Chemotherapy) 12/2012
1	Hematopoietic Stem Cell Transplantation 12/2012
1	Therapeutics 09/2012
1	Injections 01/2009